SENISCA

SENISCA, an RNA therapeutics spinout from the University of Exeter, develops technology using RNA biology to reprogram senescent cells. This addresses age-related diseases by targeting RNA splicing dysregulation, a novel component of cellular senescence, leading to cellular reprogramming and disease modification.

Buy Funded Startups lists

Funding Round:

Funding Amount:

Date: 19-Mar-2024

Investors: LifeSpan Vision Ventures

Markets: Biotechnology, RNA Therapeutics, Longevity, Health Care

HQ: Exeter, Devon, United Kingdom

Founded: 2020

Website: https://www.senisca.com/

LinkedIn: https://uk.linkedin.com/company/senisca

Twitter:

Instagram: